Related Experiment Video
Updated: Jan 9, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Delivering effective genome sequencing in pediatric care: From research in the 100,000 Genomes Project to routine
Emma Wakeling1, Rashida Baptiste2, Clarissa Rocca3
1North East Thames Regional Genetic Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Insights
Learning from the 100,000 Genomes Project (100KG) improved the National Health Service Genomic Medicine Service (GMS) for rare conditions. GMS offers higher diagnostic yields and earlier testing for children through informed genome sequencing (GS) strategies.
Area of Science:
- Genomics
- Clinical Genetics
- Rare Diseases
Background:
- Genome sequencing (GS) is crucial for diagnosing rare conditions, especially in pediatric patients.
- The 100,000 Genomes Project (100KG) paved the way for integrating GS into the UK's National Health Service (NHS).
- The NHS Genomic Medicine Service (GMS) launched in 2020, offering routine clinical GS.
Purpose of the Study:
- To evaluate how insights from the 100KG initiative influenced the delivery and outcomes of the GMS.
- To compare the effectiveness of GS in children within the GMS versus the 100KG research program.
Main Methods:
- A comparative analysis of GS outcomes in pediatric patients.
- Comparing 501 children tested through the GMS with 1759 children from the 100KG research cohort.
Main Results:
- GMS demonstrated a significantly higher diagnostic yield (29%) compared to 100KG (22%).
- GMS facilitated earlier testing, with a median age of 6 years versus 8 years in 100KG.
- GMS utilized fewer, larger gene panels, increasing the median number of genes tested per patient (2801 vs 1373).
Conclusions:
- Knowledge gained from 100KG has enhanced GMS clinical service delivery, leading to improved diagnostic rates and earlier patient intervention.
- The refined GS approach enables quicker access to personalized management strategies with reduced diagnostic investigations.
- These findings have broad implications for implementing effective GS services globally.
Purpose:
Genome sequencing (GS) is increasingly used to investigate rare conditions, primarily in children. The 100,000 Genomes Project (100KG) evaluated GS ahead of implementation in the English National Health Service. In 2020, the National Health Service Genomic Medicine Service (GMS) became the first public health care system to offer GS in routine clinical care. We investigate how learning from 100KG informed GMS service delivery.
Methods:
We compare GS outcomes in children tested at a large pediatric hospital via GMS (n = 501) and 100KG research (n = 1759).
Results:
GMS diagnostic yield (29%) was higher than that in 100KG (22%) (P < .0016). Median age at testing was 8 years in 100KG and 6 in the GMS (P < .05). In 100KG, the diagnostic yield was <10% for 15 indications, none of which are included in GMS testing. 100KG data showed little benefit to application of >3 panels. Use of fewer but larger GMS panels resulted in a significantly higher number of genes tested per patient: median 2801 vs 1373 in 100KG (P < .001). In 100KG, diagnostic yield was not significantly increased by testing more than 3 family members (n = 34/142, 24%).
Conclusion:
Learning from 100KG has informed GS clinical service delivery, resulting in higher diagnostic yields and earlier age at testing. Lessons are broadly applicable to all services providing GS, enabling earlier access to tailored management with fewer investigations.
More Related Videos
Related Concept Videos
Genomics
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Sanger Sequencing
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...

